We recently isolated a novel cDNA, designated ELKS, that was fused to RET cDNA in a papillary thyroid carcinoma. Its encoded polypeptide sequence was rich in glutamic acid (E), leucine (L), lysine (K), and serine (S), and was characterized by the presence of nine alpha-helical coiled-coil domains consisting of periodic heptad repeats. We have now cloned the entire structure of the human ELKS gene from within a 700-kb genomic region represented by overlapping bacteriophage P1-derived artificial chromosome (PAC) and bacterial artificial chromosome (BAC) clones, and localized it to chromosomal band 12p13.3 by fluorescence in situ hybridization. The gene is approximately 500 kb long, with 19 exons and 18 introns; the transcription initiation site within exon 1 is separate from the initiation codon (in exon 2). Analysis of the exon/intron structure revealed that introns interrupt the coding sequence in such a way that many functional segments of the protein are encoded by distinct exons. Exon 1 encodes the 5Ј non-coding region; exons 2, 3, 6, 7, 8, 9, 11, 14, and 15 encode the nine coiled-coil domains. Exons 17-19 constitute the 3Ј non-coding region. Analysis of the region immediately upstream of exon 1 showed that it was extremely rich in G/C nucleotides and contained multiple Sp-1 and AP2 binding sequences. The ELKS-RET gene fusion rearrangement we had observed in a papillary thyroid carcinoma occurred between intron 10 of the ELKS gene and intron 11 of RET.
Introduction
Proto-oncogenes TRKA and RET, both of which encode receptor-tyrosine kinases, are occasionally rearranged in primary papillary thyroid carcinomas. TRKA is a receptor for nerve growth factor (Klein et al. 1991) ; RET forms receptor complexes with other molecules that transmit signals of its ligands, which include glial cell line-derived neurotrophic factor (GDNF; Jing et al. 1996) , neurturin (NTN; Klein et al. 1998) , persephin (PSP; Milbrandt et al. 1998) , and artemin (Balon et al. 1998) . In affected tumors, these two genes form chimeric oncogenes by fusing their tyrosine kinase domains with 5Ј portions of different activating genes (Jhiang and Mazzaferri 1994) . Four kinds of chimeric oncogenes involving RET have been reported in papillary thyroid carcinomas: RET/PTC1 (Grieco et al. 1990 ), RET/ PTC2 (Bongarzone et al. 1993) , RET/PTC3 Jhiang and Mazzaferri 1994; Santoro et al. 1994) , and RET/PTC5 . Their 5Ј-end sequences consist of genes encoding, respectively, H4, regulatory subunit Riα of protein kinase A, RFG/ELE1, and RFG5.
Recently, we identified a novel cDNA (ELKS), the 5Ј portion of which was fused to the RET gene in a papillary thyroid carcinoma as a consequence of a translocation, t(10;12)(q11;p13) (Nakata et al. 1999) . The ELKS cDNA encodes a novel 948-amino-acid peptide that is expressed ubiquitously in human tissues. The presence of multiple coiled-coil domains in the ELKS product suggests that this protein is likely to form dimers. To investigate the molecular basis of the rearrangement we observed in the thyroid tumor, we determined the genomic structure and chromosomal localization of the human ELKS gene.
Material and methods
Cloning of full-length ELKS cDNA by 5Ј rapid amplification of cDNA ends (RACE) 5Ј RACE experiments were performed with a Marathon cDNA amplification kit (Clontech, Palo Alto, CA, USA), using human brain poly(A) RNA as starting material, according to procedures described previously (Nakajima et al. 1999b) . The adapter-ligated cDNA was subjected to two rounds of polymerase chain reactions (PCR), using a first gene-specific primer, (5Ј-CCCTCCCGTACTGTTGGTTC-GACGGTG-3Ј) that corresponds to nucleotides 488-515 of the ELKS cDNA (Nakata et al. 1999 ) and a nested genespecific primer (5Ј-GTAGGAAAGGCGAAAGCCTCA-GCACTA-3Ј) that corresponds to nucleotides 142-170 of ELKS cDNA. Sequencing was performed by the BigDye Terminator cycle-sequencing method, using a 377 ABI Prism automated DNA sequencer (ABI), as described previously (Nakajima et al. 1999a) Isolation of the human ELKS gene A bacteriophage P1-derived artificial chromosome (PAC) library and bacterial artificial chromosome (BAC) library containing human genomic DNA pooled in a threedimensional structure (Genome Systems, St. Louis, MO, USA, and Roswell Research Center, Buffalo, NY, USA) was used for the isolation of genomic clones, as described previously (Tsukamoto et al. 1998 ), using oligonucleotides designed from the ELKS cDNA sequence.
Sequence analysis of exon/intron junctions and the 5Ј-flanking region The nucleotide sequences of exons and their boundaries and the 5Ј-flanking region were determined by directly sequencing the isolated PAC and BAC clones, using oligonucleotide primers with sequence identity to ELKS cDNA (Nakata et al. 1999) . The size of each intron was determined by direct sequencing of the overlapping PAC and BAC genomic clones or estimated by PCR amplification, using LA Taq and two oppositely oriented primers located in the respective flanking exons (Takara, Tokyo, Japan) according to procedures described previously (Nakajima et al. 1999b ).
Chromosomal mapping of the human ELKS gene by fluorescence in situ hybridization (FISH) To assign the human ELKS gene location on human chromosomes, a PAC clone carrying the human PAC chromosomal gene was used as a probe. Fluorescence in situ hybridization using PAC DNA was carried out as described previously (Mukae et al. 1998) . The slides were examined through a Nikon epifluorescent microscope equipped with a change-compled device (CCD) camera (Photometrics, Tucson, AZ, USA). Images were captured with Quips (Vysis) software and processed with Adobe Photoshop 3.0 software.
Results and discussion
Genomic characterization of the ELKS gene A 700-kb genomic region containing the entire human ELKS gene was obtained from seven overlapping clones. Five of these clones (232n23, 136j23, 927j12, 60g23, and 90j10) were isolated by screening a human genomic PAC library; the other two (366a16 and 359b12) were from a human genomic BAC library. The ELKS gene spanned more than 500 kb and consisted of 19 exons interrupted by 18 introns (Fig. 1) . Intron-exon boundary sequences and exon sizes are given in Table 1 , along with intron sizes that were either determined by direct sequencing of genomic clones or estimated by PCR amplification using primers located in adjacent exons. Sequences at all exon-intron boundaries were compatible with the consensus sequence for splicing junctions, including AG-GT (Mount 1982) .
Comparison of the genomic and cDNA sequences revealed that exon 1 and the 5Ј half of exon 2 encode the 5Ј untranslated region (UTR), while the 3Ј portions of exon 2 through exon 16 are coding regions. Exon 17 encodes both the carboxyl-terminal coding region and 3Ј UTR; exons 18 and 19 encode only the 3Ј UTR.
Sequencing and characterization of the 5Ј portion of ELKS cDNA
The nucleotide sequence of the partial human ELKS cDNA that we described earlier (Nakata et al. 1999) contained the whole open reading frame (ORF) but lacked a complete sequence of its 5Ј UTR. We therefore carried out 5Ј RACE experiments and determined the full-length sequence that included an additional 12bp of cDNA sequence on the 5Ј end (Fig. 2) . In this manner we determined that the fulllength human ELKS cDNA consists of 406bp of 5Ј UTR, 2,844bp of coding sequence, and 1,705 bp of 3Ј UTR.
The putative promoter sequence of the ELKS gene was examined with the TESS program to identify any binding sites for transcription factors. The G/C-rich 5Ј-flanking region was found to contain several Sp1 sites and AP2 sites. No CAAT or TATA box was present in the 5Ј-flanking region of the ELKS gene. These features are characteristic of the promoters of housekeeping genes (Dynan 1986 ).
Chromosomal mapping PAC genomic clones served as probes to localize the ELKS gene by fluorescence in situ hybridization on metaphase chromosomes. Clear fluorescent signals were present on chromosomal band 12p13.3 (Fig. 3) . We had already linked The lowercase letters refer to intron sequences and the uppercase letters to exon sequences a The sequences of exon/intron boundaries were determined as described under Materials and Methods b The intron sizes were estimated by size-fractionating polymerase chain reaction-amplified fragments, using agarose gel electrophoresis, or by direct sequencing of PAC and BAC genomic clones, as described under Material and Methods ND; Not determined the ELKS sequence to DNA markers on 12p13 by radiation hybrid mapping, using the Stanford G3 hybrid panels (Nakata et al. 1999 ).
Exon organization and protein domains
The lower panel of Fig. 1 confirms the relationship between exon organization and protein domains that we had predicted previously (Nakata et al. 1999 ). The secondary structure of the ELKS sequence is likely to contain alpha-helical coiled-coil domains, because of the presence of heptad repeats in each of the helical-domain regions. The Multi Coil program (version 1-0, window size 2.1) predicted that ELKS protein would contain nine coiled-coil domains. The transcription-initiation site within exon 1 is separate from the initiation codon in exon 2. Exons 2-17 are coding elements; exons 17-19 encode the 3Ј UTR. Introns interrupt the protein-coding sequence in such a way that many protein segments are encoded by distinct exons; thus, each of seven coiled-coil domains are encoded by exons 2, 3, 6, 7, 11, 14, and 15, respectively. The other two coiled-coil domains are encoded by exons 7-8 and exons 8-9. An exon/intron structure of this nature indicates that the gene consists of a mosaic of exons that individually encode functional domains.
Rearrangement of ELKS and RET genes in a papillary thyroid carcinoma
We previously showed that amino acid 691 of ELKS was fused to amino acid 713 of RET in a papillary thyroid carcinoma; ie, the kinase domain of RET starting from exon 12 of the RET gene was juxtaposed to a coiled-coil structure of the 5Ј portion of the ELKS cDNA sequence (Nakata et al. 1999) . The fusion occurred at the end of exon 10 of the ELKS gene, indicating that rearrangement in the tumor genome involved intron 10 of ELKS and intron 11 of RET. Four other kinds of chimeric oncogenes involving RET have been reported by others in papillary thyroid carcinomas: RET/PTC1 (Grieco et al. 1990 ), RET/PTC2 (Bongarzone et al. 1993) , RET/PTC3 Jhiang et al. 1994; Santoro et al. 1994) , and RET/ PTC5 . Their 5Ј-end sequences consist of genes encoding, respectively, H4, regulatory subunit Riα of protein kinase A, RFG/ELE1, and RFG5. The breakpoints of RET/PTC1 and RET/PTC3 occur within intron 1 of the H4 gene and intron 5 of the ELE1 gene, respectively (Smanik et al. 1995) . The genomic breakpoints of the RET proto-oncogene in all four previously described forms of RET rearrangement had occurred within intron 11 of the RET structure, a location which separates the transmembrane domain from the tyrosine kinase domain of RET protein. As the ELKS-RET gene fusion also disrupted intron 11 of RET, our results support the idea that all RETrelated fusion genes encode proteins with a RET kinase domain at the carboxyl terminus. We previously synthesized a 35 S-Met-labeled ELKS-RET fusion protein in vitro and showed that it actually did form dimers (Nakata et al. 1999) . The combined results appear to indicate that constitutive dimerization of rearranged RET, mediated by events within intron 11 that fuse the kinase domain to genes that Fig. 3 . Chromosomal localization of human ELKS gene to 12p13.3 (arrows) by fluorescence in situ hybridization in metaphase chromosomes have coiled-coil structures, may be a general mechanism for activating RET-receptor tyrosine kinases and promoting oncogenesis in papillary thyroid carcinomas.
